BICNU

This brand name is authorized in Canada, France, Hong Kong SAR China, New Zealand, Singapore, Spain, Tunisia, Turkey.

Active ingredients

The drug BICNU contains one active pharmaceutical ingredient (API):

1	Carmustine UNII U68WG3173Y - CARMUSTINE
	Carmustine is a cell-cycle phase nonspecific antineoplastic agent of the nitrosourea type. As an alkylating agent, it can alkylate reactive sites on nucleoproteins, thus interfering with DNA and RNA synthesis and DNA repair. In addition, carmustine is known to carbamoylate lysine residues on proteins causing irreversible inactivation of enzymes including glutathione reductase.
	Read more about Carmustine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01AD01	Carmustine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AD Nitrosoureas
Discover more medicines within L01AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00297763
ES	Centro de información online de medicamentos de la AEMPS	80523
FR	Base de données publique des médicaments	61918795
HK	Department of Health Drug Office	05144
NZ	Medicines and Medical Devices Safety Authority	2116
SG	Health Sciences Authority	15502P
TN	Direction de la Pharmacie et du Médicament	5253011H
TR	İlaç ve Tıbbi Cihaz Kurumu	8680952000260